Cargando…

Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2

INTRODUCTION: Angiopoietins and their receptor Tie-2 are, in concert with VEGF-A, key mediators in angiogenesis. This study evaluates the prognostic impact of all known human angiopoietins (Ang-1, Ang-2 and Ang-4) and their receptor Tie-2, as well as their relation to the prognostic expression of VE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersen, Sigve, Donnem, Tom, Al-Shibli, Khalid, Al-Saad, Samer, Stenvold, Helge, Busund, Lill-Tove, Bremnes, Roy M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095634/ https://www.ncbi.nlm.nih.gov/pubmed/21603628 http://dx.doi.org/10.1371/journal.pone.0019773

Ejemplares similares

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
por: Stenvold, Helge, et al.
Publicado: (2014)

Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
por: Andersen, Sigve, et al.
Publicado: (2011)

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
por: Eilertsen, Marte, et al.
Publicado: (2014)

Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
por: Donnem, Tom, et al.
Publicado: (2011)

High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome
por: Stenvold, Helge, et al.
Publicado: (2014)

MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer
por: Donnem, Tom, et al.
Publicado: (2012)

Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
por: Hald, Sigurd M., et al.
Publicado: (2015)

Erratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
por: Hald, Sigurd M., et al.
Publicado: (2016)

Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
por: Kiselev, Yury, et al.
Publicado: (2018)

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers
por: Kilvaer, Thomas K., et al.
Publicado: (2015)

Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2011)

The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
por: Kilvaer, Thomas K, et al.
Publicado: (2016)

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
por: Al-Saad, Samer, et al.
Publicado: (2017)

Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
por: Kilvaer, Thomas K, et al.
Publicado: (2014)

Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2013)

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time
por: Andersen, Sigve, et al.
Publicado: (2014)

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
por: Nordby, Yngve, et al.
Publicado: (2017)

Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2012)

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
por: Smeland, Eivind, et al.
Publicado: (2012)

Profiling of VEGFs and VEGFRs as Prognostic Factors in Soft Tissue Sarcoma: VEGFR-3 Is an Independent Predictor of Poor Prognosis
por: Kilvaer, Thomas K., et al.
Publicado: (2010)

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
por: Al-Saad, S, et al.
Publicado: (2008)

CD45RO(+) Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer()
por: Paulsen, Erna-Elise, et al.
Publicado: (2015)

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
por: Rakaee, Mehrdad, et al.
Publicado: (2016)

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure
por: Grindstad, Thea, et al.
Publicado: (2015)

The Prognostic Impact of TGF-β1, Fascin, NF-κB and PKC-ζ Expression in Soft Tissue Sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011)

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
por: Paulsen, Erna-Elise, et al.
Publicado: (2023)

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
por: Paulsen, Erna-Elise, et al.
Publicado: (2017)

The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011)

Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression
por: Grindstad, Thea, et al.
Publicado: (2018)

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry()
por: Rakaee, Mehrdad, et al.
Publicado: (2019)

Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer - A Structured Review with Meta-Analysis
por: Kilvaer, Thomas K., et al.
Publicado: (2015)

Digitally quantified CD8(+) cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
por: Kilvaer, Thomas K, et al.
Publicado: (2020)

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
por: Richardsen, Elin, et al.
Publicado: (2017)

A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
por: Skjefstad, Kaja, et al.
Publicado: (2018)

MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
por: Richardsen, Elin, et al.
Publicado: (2019)

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC
por: Kilvaer, Thomas Karsten, et al.
Publicado: (2019)

High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?
por: Nordby, Yngve, et al.
Publicado: (2017)

Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6
por: Melbø-Jørgensen, Christian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3fi0k8b2qr90t8olpnsm2nf8ko